The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation
- PMID: 34174288
- PMCID: PMC8326427
- DOI: 10.1016/j.jbc.2021.100914
The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation
Abstract
GGGGCC (G4C2) hexanucleotide repeat expansions in the endosomal trafficking gene C9orf72 are the most common genetic cause of ALS and frontotemporal dementia. Repeat-associated non-AUG (RAN) translation of this expansion through near-cognate initiation codon usage and internal ribosomal entry generates toxic proteins that accumulate in patients' brains and contribute to disease pathogenesis. The helicase protein DEAH-box helicase 36 (DHX36-G4R1) plays active roles in RNA and DNA G-quadruplex (G4) resolution in cells. As G4C2 repeats are known to form G4 structures in vitro, we sought to determine the impact of manipulating DHX36 expression on repeat transcription and RAN translation. Using a series of luciferase reporter assays both in cells and in vitro, we found that DHX36 depletion suppresses RAN translation in a repeat length-dependent manner, whereas overexpression of DHX36 enhances RAN translation from G4C2 reporter RNAs. Moreover, upregulation of RAN translation that is typically triggered by integrated stress response activation is prevented by loss of DHX36. These results suggest that DHX36 is active in regulating G4C2 repeat translation, providing potential implications for therapeutic development in nucleotide repeat expansion disorders.
Keywords: ALS (Lou Gehrig's disease); C9orf72; DHX36–G4R1–RHAU; DNA helicase; G-quadruplex; RNA helicase; dipeptide repeat proteins; fragile X; repeat-associated non-AUG translation.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest P. K. T. served as a paid consultant for Denali Therapeutics, holds a joint patent with Ionis Therapeutics, and receives publishing royalties from UpToDate. None of these are directly relevant to his role on this article, and none of these organizations have any role in the conception, preparation, or editing of this article. All other authors declare that they have no conflicts of interest with the contents of this article.
Figures
Similar articles
-
A Helicase Unwinds Hexanucleotide Repeat RNA G-Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation.J Am Chem Soc. 2021 May 19;143(19):7368-7379. doi: 10.1021/jacs.1c00131. Epub 2021 Apr 15. J Am Chem Soc. 2021. PMID: 33855846 Free PMC article.
-
Zfp106 binds to G-quadruplex RNAs and inhibits RAN translation and formation of RNA foci caused by G4C2 repeats.Proc Natl Acad Sci U S A. 2024 Jul 30;121(31):e2220020121. doi: 10.1073/pnas.2220020121. Epub 2024 Jul 23. Proc Natl Acad Sci U S A. 2024. PMID: 39042693
-
FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD.Elife. 2023 Jul 18;12:RP84338. doi: 10.7554/eLife.84338. Elife. 2023. PMID: 37461319 Free PMC article.
-
C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.Autophagy. 2021 Nov;17(11):3306-3322. doi: 10.1080/15548627.2021.1872189. Epub 2021 Feb 26. Autophagy. 2021. PMID: 33632058 Free PMC article. Review.
-
RNA-mediated toxicity in C9orf72 ALS and FTD.Neurobiol Dis. 2020 Nov;145:105055. doi: 10.1016/j.nbd.2020.105055. Epub 2020 Aug 21. Neurobiol Dis. 2020. PMID: 32829028 Free PMC article. Review.
Cited by
-
Causes, functions, and therapeutic possibilities of RNA secondary structure ensembles and alternative states.Cell Chem Biol. 2024 Jan 18;31(1):17-35. doi: 10.1016/j.chembiol.2023.12.010. Epub 2024 Jan 9. Cell Chem Biol. 2024. PMID: 38199037 Free PMC article. Review.
-
Differential Gene Expression following DHX36/G4R1 Knockout Is Associated with G-Quadruplex Content and Cancer.Int J Mol Sci. 2024 Feb 1;25(3):1753. doi: 10.3390/ijms25031753. Int J Mol Sci. 2024. PMID: 38339029 Free PMC article.
-
Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases.Mol Neurobiol. 2024 Dec;61(12):10722-10735. doi: 10.1007/s12035-024-04239-9. Epub 2024 May 23. Mol Neurobiol. 2024. PMID: 38780719 Review.
-
Reconstitution of C9orf72 GGGGCC repeat-associated non-AUG translation with purified human translation factors.Sci Rep. 2023 Dec 20;13(1):22826. doi: 10.1038/s41598-023-50188-z. Sci Rep. 2023. PMID: 38129650 Free PMC article.
-
G-Quadruplexes in Repeat Expansion Disorders.Int J Mol Sci. 2023 Jan 25;24(3):2375. doi: 10.3390/ijms24032375. Int J Mol Sci. 2023. PMID: 36768697 Free PMC article. Review.
References
-
- Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–268. - PMC - PubMed
-
- DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–256. - PMC - PubMed
-
- Van Mossevelde S., van der Zee J., Cruts M., Van Broeckhoven C. Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 2017;44:117–124. - PubMed
-
- Byrne S., Heverin M., Elamin M., Walsh C., Hardiman O. Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:148–150. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
